ResearchAssociate (CRA) and play a crucial role in ensuring the meticulous execution and documentation of clinical studies... match for all current and upcoming ClinicalResearchAssociate roles. By applying, we’ll match your profile on a continuous...
and externally. Acts as primary site contact and site manager throughout all phases of a clinicalresearch study, taking overall... responsibility of allocated sites. Actively develops and expands the territory for clinicalresearch, finding and developing new...
JOB DESCRIPTION About the Opportunity: The ClinicalResearchAssociate (CRA) is primarily responsible for ensuring the..., expedited, and smooth management of clinical trials. In collaboration with the In-house ClinicalResearchAssociate (IHCRA...
JOB DESCRIPTION About the Opportunity: The ClinicalResearchAssociate (CRA) is primarily responsible for ensuring the..., expedited, and smooth management of clinical trials. In collaboration with the In-house ClinicalResearchAssociate (IHCRA...
Job Description: About the Opportunity: The ClinicalResearchAssociate (CRA) is primarily responsible for ensuring..., expedited, and smooth management of clinical trials. In collaboration with the In-house ClinicalResearchAssociate (IHCRA...
) to receive an alert: × Select how often (in days) to receive an alert: Associate Market Access Manager - Obesity & CETA... for you to join our team as an Associate Market Access Manager for Obesity and Cardiovascular & Emerging Therapy Areas (CETA...
for you to join our team as an Associate Market Access Manager for Obesity and Cardiovascular & Emerging Therapy Areas (CETA... our aspirations to establish a global presence in the industry. The position As an Associate Market Access Manager Obesity & CETA...
? If so, we have an exciting opportunity for you to join our team as an Associate Market Access Manager for Obesity... As an Associate Market Access Manager Obesity & CETA, you will manage MAPA related projects as well as you will play a critical role...
. As a ClinicalResearchAssociate at ICON, you’ll work within a large-scale, fast-paced environment alongside a close-knit team... and Integrity. We want to be the ClinicalResearch Organisation that delivers excellence to our clients and to patients at every...
. Job responsibilities The ClinicalResearchAssociate II (CRA II) will perform monitoring and site management activities for Phase I-IV... clinicalresearch projects to assess the progress of clinical projects at assigned investigative/physician sites...
India end their 13-year wait for a world title by fighting back for a thrilling seven-run win over South Africa in the T20 World Cup final. Continue Reading »
The shares of Emcure Pharma IPO is trading at a premium of ₹255 in the grey market premium (GMP) on Saturday, June 29, just days before the issue opens for subscription, according to investorgain.com. Continue Reading »
Dividend Stocks: Several companies including Mahindra & Mahindra, Piramal Enterprises, Tata Power, among others are trading ex-dividend in the coming week. Continue Reading »
According to Ravi Singh, SVP- Retail Research, Religare Broking Ltd, Infrastructure investment is set to focus on sustainability, aiming to modernize transport networks and improve environmental outcomes. Continue Reading »
Nike, the world’s largest sportswear company has been seeing a revenue decline to the mid-single digits in the company’s current fiscal year, while investors had expected an increase. Continue Reading »
Mid and small-cap stocks in India have shown strong performance, but high valuations make them volatile. Experts advise a cautious approach and suggest focusing on quality stocks for potential alpha returns. Selectivity and bottom-up investment approach are recommended for long-term wealth creation. Continue Reading »
The final date for Vraj Iron and Steel IPO bidding has passed, with allotment expected on July 1, 2024. The issue price range was ₹195-207, with shares trading at a 75% premium in the grey market. Continue Reading »
FPI inflows into Indian equities were modest in the first half of 2024 but surged in June with ₹26,565 crore. Experts predict a strong second half due to economic growth prospects, potential rate cuts, and positive sentiment. Continue Reading »